IHM
KYNB

Iguana Healthcare Management’s Kyntra Bio KYNB Stock Holding History

Iguana Healthcare Management’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,600
Closed -$2.15M – 66
2017
Q3 		$2.15M Buy
+1,600
New +$1.69M 1.17% 32

Other funds holding KYNB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Iguana Healthcare Management's KYNB Position: Q4 2017 in Review

Iguana Healthcare Management sold out of Kyntra Bio (KYNB) in Q4 2017, closing a stake of 1,600 shares — an estimated $2.15M sold.

Iguana Healthcare Management first reported a position in KYNB in Q3 2017 and held it in 1 quarter. The position peaked at $2.15M in Q3 2017. 187 funds tracked by Wall St. Rank hold KYNB as of Q4 2017.

  • Iguana Healthcare Management reported no remaining Kyntra Bio position as of Q4 2017 after selling out during the quarter.
  • Iguana Healthcare Management sold 1,600 Kyntra Bio shares in Q4 2017, an estimated $2.15M.
  • Iguana Healthcare Management first reported a position in Kyntra Bio in Q3 2017 and held it in 1 quarter.
  • Iguana Healthcare Management's Kyntra Bio position peaked at $2.15M in Q3 2017.
  • 187 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2017.

Based on Iguana Healthcare Management's 13F filing for Q4 2017, filed 14 Feb 2018.